EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Design, synthesis, in vitro , and in silico studies of novel isatin-hybrid hydrazones as potential triple-negative breast cancer agents

Iqra Munir, Zahra Batool, Faizullah Khan, Javid Hussain, Ajmal Khan, Suraj N Mali iD, Vishnu Vasanthi Radhakrishnan iD, Bijo Mathew iD, Tahani Mazyad Almutairi, Ahmed Al-Harrasi iD, Muhammad Safwan Akram iD, Zahid Shafiq iD

RSC Advances · 2025 · 15 (2) · 948-965

DOI: 10.1039/d4ra07650h ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2025. Verfasst von Iqra Munir und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Sciences, Bahauddin Zakariya University Multan-60800 Pakistan zahidshafiq@bzu.edu.pk. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: King Saud University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advances in cancer therapy have been made possible by monoclonal antibodies, domain antibodies, antibody drug conjugates, etc.

Autor:innen und Institutionen

  • Institute of Chemical Sciences, Bahauddin Zakariya University Multan-60800 Pakistan zahidshafiq@bzu.edu.pk.
  • Department of Pharmacy, Abdul Wali Khan University Mardan KPK Pakistan aharrasi@unizwa.edu.om.
  • Natural and Medical Sciences Research Centre, University of Nizwa P. O. Box 33, PC 616, Birkat Al Mauz Nizwa Sultanate of Oman.
  • Department of Biological Sciences and Chemistry, University of Nizwa Oman.
  • Department of Chemical and Biological Engineering, College of Engineering, Korea University 145 Anam-ro, Seongbuk-gu Seoul 02841 Republic of Korea.
  • School of Pharmacy, DY Patil Deemed To Be University Navi Mumbai India.

ORCID-Profile: Suraj N Mali, Vishnu Vasanthi Radhakrishnan, Bijo Mathew, Ahmed Al-Harrasi, Muhammad Safwan Akram, Zahid Shafiq

Förderung

  • King Saud University

Zitieren

APA

Munir, I., Batool, Z., Khan, F., Hussain, J., Khan, A., Mali, S. N., Radhakrishnan, V. V., Mathew, B., Almutairi, T. M., Al-Harrasi, A., Akram, M. S., & Shafiq, Z. (2025). Design, synthesis, in vitro , and in silico studies of novel isatin-hybrid hydrazones as potential triple-negative breast cancer agents. RSC Advances, 15(2), 948-965. https://doi.org/10.1039/d4ra07650h

Vancouver

Munir I, Batool Z, Khan F, Hussain J, Khan A, Mali SN, et al. Design, synthesis, in vitro , and in silico studies of novel isatin-hybrid hydrazones as potential triple-negative breast cancer agents. RSC Advances. 2025;15(2):948-965. doi:10.1039/d4ra07650h

BibTeX
@article{Munir2025,
  author = {Munir, Iqra and Batool, Zahra and Khan, Faizullah and Hussain, Javid and Khan, Ajmal and Mali, Suraj N and Radhakrishnan, Vishnu Vasanthi and Mathew, Bijo and Almutairi, Tahani Mazyad and Al-Harrasi, Ahmed and Akram, Muhammad Safwan and Shafiq, Zahid},
  title = {Design, synthesis, in vitro , and in silico studies of novel isatin-hybrid hydrazones as potential triple-negative breast cancer agents},
  journal = {RSC Advances},
  year = {2025},
  volume = {15},
  number = {2},
  pages = {948--965},
  doi = {10.1039/d4ra07650h}
}
Kostenlos starten →